FDA Approves DEXMETHYLPHENIDATE HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced late Friday that the FDA has granted tentative approval for its generic version of the ADHD medication dexmethylphenidate hydrochloride. This approval has significant market implications as it sets the stage for increased generic competition within the stimulant class.